BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19504909)

  • 1. Co-synthesis and drug delivery properties of mesoporous hydroxyapatite-silica composites.
    Zhao YF; Loo SC; Ma J
    J Nanosci Nanotechnol; 2009 Jun; 9(6):3720-7. PubMed ID: 19504909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
    Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
    J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wet powder processing of sol-gel derived mesoporous silica-hydroxyapatite hybrid powders.
    Andersson J; Johannessen E; Areva S; Järn M; Lindén M
    J Nanosci Nanotechnol; 2006 Aug; 6(8):2438-44. PubMed ID: 17037853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption.
    Huang S; Li C; Cheng Z; Fan Y; Yang P; Zhang C; Yang K; Lin J
    J Colloid Interface Sci; 2012 Jun; 376(1):312-21. PubMed ID: 22444483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembly of nanohydroxyapatite in mesoporous silica.
    Shi X; Wang Y; Wei K; Ren L; Lai C
    J Mater Sci Mater Med; 2008 Aug; 19(8):2933-40. PubMed ID: 18360795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of mesoporous hollow silica nanospheres using polymeric micelles as template and their application as a drug-delivery carrier.
    Sasidharan M; Zenibana H; Nandi M; Bhaumik A; Nakashima K
    Dalton Trans; 2013 Oct; 42(37):13381-9. PubMed ID: 23887599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Characterization of Mesoporous Mg- and Sr-Doped Nanoparticles for Moxifloxacin Drug Delivery in Promising Tissue Engineering Applications.
    Pouroutzidou GK; Liverani L; Theocharidou A; Tsamesidis I; Lazaridou M; Christodoulou E; Beketova A; Pappa C; Triantafyllidis KS; Anastasiou AD; Papadopoulou L; Bikiaris DN; Boccaccini AR; Kontonasaki E
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vitro characterisation of bioactive mesoporous silica microparticles for drug delivery applications.
    Prokopowicz M; Czarnobaj K; Szewczyk A; Sawicki W
    Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():7-18. PubMed ID: 26706501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
    Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
    Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scaffolds for bone regeneration made of hydroxyapatite microspheres in a collagen matrix.
    Cholas R; Kunjalukkal Padmanabhan S; Gervaso F; Udayan G; Monaco G; Sannino A; Licciulli A
    Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():499-505. PubMed ID: 27040244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
    Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of mesoporous carbons using ordered and disordered mesoporous silica templates and polyacrylonitrile as carbon precursor.
    Kruk M; Dufour B; Celer EB; Kowalewski T; Jaroniec M; Matyjaszewski K
    J Phys Chem B; 2005 May; 109(19):9216-25. PubMed ID: 16852101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic property measurement of surfactant-templated mesoporous silica films using time-resolved single-molecule imaging.
    Kennard R; DeSisto WJ; Giririjan TP; Mason MD
    J Chem Phys; 2008 Apr; 128(13):134710. PubMed ID: 18397097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
    Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
    Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of hydroxyapatite in a biocompatible mesoporous ordered silica.
    Díaz A; López T; Manjarrez J; Basaldella E; Martínez-Blanes JM; Odriozola JA
    Acta Biomater; 2006 Mar; 2(2):173-9. PubMed ID: 16701875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery.
    Sousa A; Souza KC; Sousa EM
    Acta Biomater; 2008 May; 4(3):671-9. PubMed ID: 18206431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sol-gel synthesis of a multifunctional, hierarchically porous silica/apatite composite.
    Andersson J; Areva S; Spliethoff B; Lindén M
    Biomaterials; 2005 Dec; 26(34):6827-35. PubMed ID: 15993485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in situ synthesis of mesoporous SBA-16/hydroxyapatite for ciprofloxacin release: in vitro stability and cytocompatibility studies.
    Andrade GF; Gomide VS; da Silva Júnior AC; Goes AM; de Sousa EM
    J Mater Sci Mater Med; 2014 Nov; 25(11):2527-40. PubMed ID: 25056197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.